Domestic Systemically Important Banks: Why are these banks ‘too big to fail’?
All three banks continue to be under the same bucketing structure as in the 2023 list of D-SIBs, the regulator said.
Gilead, Vertex initiated as new big biotech buys at Citi
Citi has started coverage of Gilead Sciences (NASDAQ:GILD) and Vertex Pharmaceuticals (NASDAQ:VRTX) at buy saying the former will benefit from short-term growth of Biktarvy (bictegravir, emtricitabine ...